Literature DB >> 2438684

Production of a monoclonal antibody with specificity for the pellicle of Pneumocystis carinii by hybridoma.

Y Matsumoto, T Amagai, M Yamada, J Imanishi, Y Yoshida.   

Abstract

This study reports the establishment of cloned hybridomas between mouse myeloma cells (P3-X63-Ag8, 6.5.3) and spleen cells from BALB/c mice immunized with lung homogenates of nude mice (BALB/c nu/nu) heavily infected with Pneumocystis carinii. A hybridoma subclone, designated 1E12-8, produced antibodies of an IgG1 subclass. Using indirect immunofluorescent antibody techniques, the monoclonal antibody was found to be directed toward the pellicle antigen of air-dried P. carinii both in trophozoite and cyst forms, and to recognize the P. carinii antigen not only from nude mice but also from rats. The antibody did not cross-react with other components of the infected host lung tissue and showed little cross-reactivity with fungi examined. The monoclonal antibody should be useful in the isolation and identification of corresponding antigenic substances of P. carinii and may provide a useful tool in epidemiology, taxonomy, and diagnosis of this organism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438684     DOI: 10.1007/bf00578509

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  21 in total

1.  IDENTIFICATION OF PNEUMOCYSTIS CARINII ANTIGENS IN TISSUES.

Authors:  W J BRZOSKO; A NOWOSLAWSKI
Journal:  Bull Acad Pol Sci Biol       Date:  1965

2.  Localization of gamma-globulin in the diseased kidney.

Authors:  P FREEDMAN; J H PETERS; R M KARK
Journal:  Arch Intern Med       Date:  1960-04

3.  Pneumocystis carinii: new separation method from lung tissue.

Authors:  P D Walzer; M E Rutledge; K Yoneda; B J Stahr
Journal:  Exp Parasitol       Date:  1979-06       Impact factor: 2.011

4.  Studies of morphology and immunofluorescence of Pneumocystis carinii.

Authors:  H K Kim; W T Hughes; S Feldman
Journal:  Proc Soc Exp Biol Med       Date:  1972-10

5.  Pneumocystis jiroveci n. sp. from man: morphology, physiology, and immunology in relation to pathology.

Authors:  J K Frenkel
Journal:  Natl Cancer Inst Monogr       Date:  1976-10

6.  Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children.

Authors:  L L Pifer; W T Hughes; S Stagno; D Woods
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

7.  Production of monoclonal antibody against Pneumocystis carinii by using a hybrid of rat spleen and mouse myeloma cells.

Authors:  C H Lee; C D Bolinger; M S Bartlett; R B Kohler; C E Wilde; J W Smith
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

8.  Development and characterization of monoclonal antibodies to Pneumocystis carinii.

Authors:  D C Graves; S J McNabb; M H Ivey; M A Worley
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

9.  Comparison of histological and immunological techniques for detection of Pneumocystis carinii in rat bronchial lavage fluid.

Authors:  J E Milder; P D Walzer; J D Coonrod; M E Rutledge
Journal:  J Clin Microbiol       Date:  1980-04       Impact factor: 5.948

10.  Prospective evaluation of a monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia.

Authors:  J A Kovacs; V Gill; J C Swan; F Ognibene; J Shelhamer; J E Parrillo; H Masur
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321

View more
  3 in total

1.  Expression, structure, and location of epitopes of the major surface glycoprotein of Pneumocystis carinii f. sp. carinii.

Authors:  M J Linke; S M Sunkin; R P Andrews; J R Stringer; P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

2.  Outbreaks of Pneumocystis carinii pneumonia in colonies of immunodeficient mice.

Authors:  P D Walzer; C K Kim; M J Linke; C L Pogue; M J Huerkamp; C E Chrisp; A V Lerro; S K Wixson; E Hall; L D Shultz
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

3.  Properties of the major antigens of rat and human Pneumocystis carinii.

Authors:  M J Linke; M T Cushion; P D Walzer
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.